BRIEF—Jazz Pharma nabs Sunesis CEO as new president and chief operating officer

Nasdaq-listed Jazz Pharmaceuticals has made current Sunesis Pharmaceuticals president and CEO Daniel Swisher its new president and chief operating officer, effective January.

Current COO Russell Cox has resigned, and will become CEO of another biotech, “focused on helping patients with acute forms of liver failure.”

Mr Swisher served in various management roles, including senior vice president of sales and marketing, for ALZA Corporation from 1992 to 2001.

Chief executive Bruce Cozadd said: "Dan will complement our current strong leadership team as we grow and expand our global operations and further diversify our commercial and R&D portfolios.”